Private Advisor Group LLC lessened its stake in shares of Mazor Robotics Ltd – (NASDAQ:MZOR) by 56.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 6,509 shares of the medical instruments supplier’s stock after selling 8,325 shares during the quarter. Private Advisor Group LLC’s holdings in Mazor Robotics were worth $375,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the business. Gilder Gagnon Howe & Co. LLC boosted its stake in Mazor Robotics by 3.0% during the third quarter. Gilder Gagnon Howe & Co. LLC now owns 238,647 shares of the medical instruments supplier’s stock worth $11,782,000 after buying an additional 6,905 shares during the period. Candriam Luxembourg S.C.A. boosted its stake in Mazor Robotics by 1.9% during the third quarter. Candriam Luxembourg S.C.A. now owns 159,052 shares of the medical instruments supplier’s stock worth $7,852,000 after buying an additional 2,983 shares during the period. Sumitomo Mitsui Trust Holdings Inc. purchased a new position in Mazor Robotics during the third quarter worth about $6,371,000. EAM Investors LLC boosted its stake in Mazor Robotics by 68.2% during the third quarter. EAM Investors LLC now owns 119,083 shares of the medical instruments supplier’s stock worth $5,879,000 after buying an additional 48,299 shares during the period. Finally, Global X MANAGEMENT CO LLC boosted its stake in Mazor Robotics by 5,758.8% during the third quarter. Global X MANAGEMENT CO LLC now owns 115,536 shares of the medical instruments supplier’s stock worth $5,704,000 after buying an additional 113,564 shares during the period. 26.42% of the stock is owned by institutional investors.
MZOR has been the subject of several recent research reports. Zacks Investment Research lowered shares of Mazor Robotics from a “buy” rating to a “hold” rating in a research note on Thursday, February 1st. Needham & Company LLC reissued a “hold” rating on shares of Mazor Robotics in a research note on Wednesday, February 14th. BidaskClub lowered shares of Mazor Robotics from a “buy” rating to a “hold” rating in a research note on Tuesday, January 23rd. TheStreet raised shares of Mazor Robotics from a “d” rating to a “c-” rating in a research note on Wednesday, November 8th. Finally, Ladenburg Thalmann Financial Services set a $67.00 price objective on shares of Mazor Robotics and gave the company a “buy” rating in a research note on Monday, October 30th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $44.50.
Mazor Robotics (NASDAQ:MZOR) last posted its quarterly earnings data on Wednesday, February 14th. The medical instruments supplier reported $0.02 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.07) by $0.09. Mazor Robotics had a negative net margin of 19.08% and a negative return on equity of 14.03%. The business had revenue of $19.15 million during the quarter, compared to analyst estimates of $19.00 million. During the same quarter last year, the firm posted ($0.07) earnings per share. The business’s revenue for the quarter was up 36.4% compared to the same quarter last year. analysts expect that Mazor Robotics Ltd – will post 0.06 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This article was first posted by Ticker Report and is the property of of Ticker Report. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/3225268/mazor-robotics-ltd-mzor-shares-sold-by-private-advisor-group-llc.html.
About Mazor Robotics
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include Renaissance Guidance System, which can improve the execution and outcomes in a wide variety of procedures, including percutaneous degenerative repair, pedicle screw fixation for complex spinal deformity, and vertebral augmentation; Mazor X, the Surgical Assurance Platform for Spine Surgery.
Want to see what other hedge funds are holding MZOR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mazor Robotics Ltd – (NASDAQ:MZOR).
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.